Be a Smart Investor
Monday, January 7, 2019
GlaxoSmithKline CEO Emma Walmsley gets 'radical' about reshaping portfolio
After announcing two major deals last month, GlaxoSmithKline CEO Emma Walmsley is still looking for more chances to transform Britain's largest drugmaker.
from Deals and IPOs https://cnb.cx/2C6rsoJ
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment